Notoya M - Search Results

1

Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.

Kuroda T, Masui M, Notoya M, Ito M, Tamura Y, Okamoto H, Kanaoka E, Shinosaki T. Kuroda T, et al. Among authors: notoya m. Nephron Extra. 2012 Jan;2(1):133-46. doi: 10.1159/000338801. Epub 2012 May 26. Nephron Extra. 2012. PMID: 22739248 Free PMC article.

2

Glomerular epithelial cell injury accelerates the progression of antibody-induced mesangial proliferative nephritis.

Shinosaki T, Notoya M, Nomura Y, Miyai I, Kobayashi T, Kurihara H. Shinosaki T, et al. Among authors: notoya m. Exp Nephrol. 2002;10(4):245-58. doi: 10.1159/000063699. Exp Nephrol. 2002. PMID: 12097828

3

Intussusceptive capillary growth is required for glomerular repair in rat Thy-1.1 nephritis.

Notoya M, Shinosaki T, Kobayashi T, Sakai T, Kurihara H. Notoya M, et al. Kidney Int. 2003 Apr;63(4):1365-73. doi: 10.1046/j.1523-1755.2003.00876.x. Kidney Int. 2003. PMID: 12631352 Free article.

4

Altered expression of matrix-related molecules in the development of chronic Thy1.1 nephritis.

Kuroda T, Tanioka H, Masui M, Ito M, Notoya M, Shinosaki T. Kuroda T, et al. Among authors: notoya m. Nephron Exp Nephrol. 2006;104(4):e169-82. doi: 10.1159/000096068. Epub 2006 Oct 5. Nephron Exp Nephrol. 2006. PMID: 17028444

5

Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation.

Kobayashi T, Notoya M, Shinosaki T, Kurihara H. Kobayashi T, et al. Among authors: notoya m. Nephron Exp Nephrol. 2009;113(3):e89-96. doi: 10.1159/000235245. Epub 2009 Aug 14. Nephron Exp Nephrol. 2009. PMID: 19684413

6

Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.

Kobayashi T, Akiyama Y, Akiyama N, Katoh H, Yamamoto S, Funatsuki K, Yanagimoto T, Notoya M, Asakura K, Shinosaki T, Hanasaki K. Kobayashi T, et al. Among authors: notoya m. Eur J Pharmacol. 2010 Dec 15;649(1-3):23-8. doi: 10.1016/j.ejphar.2010.08.037. Epub 2010 Sep 6. Eur J Pharmacol. 2010. PMID: 20826135

7

N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?

Yoshimura N, Yamada K, Ono T, Notoya M, Yukioka H, Takahashi R, Wakino S, Kanda T, Itoh H. Yoshimura N, et al. Among authors: notoya m. Clin Exp Nephrol. 2023 Nov;27(11):901-911. doi: 10.1007/s10157-023-02379-1. Epub 2023 Jul 25. Clin Exp Nephrol. 2023. PMID: 37490135

8

A Novel Acetyl-CoA Carboxylase 2 Selective Inhibitor Improves Whole-Body Insulin Resistance and Hyperglycemia in Diabetic Mice through Target-Dependent Pathways.

Takagi H, Tanimoto K, Shimazaki A, Tonomura Y, Momosaki S, Sakamoto S, Abe K, Notoya M, Yukioka H. Takagi H, et al. Among authors: notoya m. J Pharmacol Exp Ther. 2020 Mar;372(3):256-263. doi: 10.1124/jpet.119.263590. Epub 2020 Jan 3. J Pharmacol Exp Ther. 2020. PMID: 31900320

9

High resolution localization of endothelin receptors in rat renal medulla.

Yukimura T, Notoya M, Mizojiri K, Mizuhira V, Matsuura T, Ebara T, Miura K, Kim S, Iwao H, Song K. Yukimura T, et al. Among authors: notoya m. Kidney Int. 1996 Jul;50(1):135-47. doi: 10.1038/ki.1996.296. Kidney Int. 1996. PMID: 8807582 Free article.

10

Clearance of group X secretory phospholipase A(2) via mouse phospholipase A(2) receptor.

Yokota Y, Notoya M, Higashino K, Ishimoto Y, Nakano K, Arita H, Hanasaki K. Yokota Y, et al. Among authors: notoya m. FEBS Lett. 2001 Dec 7;509(2):250-4. doi: 10.1016/s0014-5793(01)03173-8. FEBS Lett. 2001. PMID: 11741598 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters